Deadline: 25-Sep-2026
The Biotech Call for Network Projects supports international partnerships in biotechnology to develop high-impact, market-ready solutions. Projects focus on biomanufacturing, next-generation therapeutics, agricultural and veterinary biotech, and advanced diagnostics, fostering cross-border collaboration within the Eureka Network.
Purpose of the Call
The initiative aims to:
- Support innovation in biotech fields including medicine, life sciences, and process technologies
- Enable small-scale, well-defined projects with clear implementation and commercialisation potential
- Encourage international collaboration across participating countries to create mutual benefits
- Promote technological integration, sustainability, and cross-sectoral transfer in biotech applications
Focus Areas
1. Advanced Biomanufacturing & Ecosystem Enablers
- Scale-up and manufacturing of complex therapies
- Micro-factories for decentralised biomanufacturing
- Sustainable and green biomanufacturing
- Supply chain resilience and traceability
- Technology transfer optimisation and cross-sectoral integration
2. Next-Generation Therapeutics & Modalities
- Innovative cancer treatments
- Targeted radiopharmaceuticals and mRNA-based vaccines
- Microbiome-based therapies and diagnostics
- Exosome-based delivery systems
- Innovative antibiotics and neuroscience-focused modalities
3. Agricultural & Veterinary Innovations
- Agricultural biotechnology solutions
- Development of veterinary therapies
- Integration of omics data into agronomic decision-making
4. Advanced Diagnostics & Data Technologies
- Bioinformatics and AI for biotech applications
- On-site molecular diagnostics
- In-situ biosensors for environmental monitoring
Who is Eligible?
Eligible consortia must:
- Include at least two independent legal entities from two or more participating countries
- Ensure no single organisation or country contributes more than 70% of the project budget
- Include organisations from non-participating countries only if they secure their own funding
Participating countries: Austria, Belgium (Flanders & Wallonia), Canada, Chile, Estonia, Germany, Lithuania, Netherlands, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, and Türkiye
Funding and Project Requirements
- Each country evaluates and funds its own partners within the consortium
- Projects should demonstrate clear innovation, technical feasibility, and a pathway to commercialisation
- Emphasis on well-balanced consortia where all partners add value
Networking and Collaboration Opportunities
The Swiss Eureka Chair is hosting the Global Innovation Summit in Basel on May 6, 2026, alongside Swiss Biotech Day. This event provides opportunities to:
- Connect with potential partners
- Explore cross-border collaborations
- Form consortia aligned with the call’s objectives
How to Apply
- Form a consortium including at least two independent legal entities from different participating countries
- Define a clear project plan, implementation timeline, and mutual benefits for all partners
- Ensure budget allocation adheres to the 70% per country/organisation limit
- Submit applications according to the rules of each country’s funding agency
- Attend networking events to identify potential partners and strengthen project proposals
Common Mistakes to Avoid
- Including only one country or entity as the main contributor
- Failing to demonstrate a clear path to commercialisation
- Ignoring cross-sectoral innovation or collaborative value
- Missing deadlines for country-specific submissions
Frequently Asked Questions (FAQs)
- Which countries can participate? Austria, Belgium (Flanders & Wallonia), Canada, Chile, Estonia, Germany, Lithuania, Netherlands, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, and Türkiye.
- Can non-participating countries join? Yes, if they provide their own funding.
- What is the minimum consortium requirement? At least two independent legal entities from two different countries.
- Are individual organisations eligible? No, only consortia meeting the criteria.
- What types of projects are supported? Small-scale, innovative biotech projects with commercialisation potential.
- Is cross-sector collaboration required? Strongly encouraged to add value across the consortium.
- Are there networking opportunities? Yes, at the Global Innovation Summit in Basel on May 6, 2026.
Conclusion
The Biotech Call for Network Projects 2026 promotes international collaboration to advance innovative biotech solutions with high market potential. By combining expertise across countries, sectors, and disciplines, this program strengthens global biotechnology ecosystems while fostering commercial impact, sustainability, and cross-border innovation.
For more information, visit Eureka Network.